Oncology Nurses as Patient Advocates

Article

Oncology nurses can make the world of a difference when it comes to patient care, and it is crucial that they work together with other members of the treatment team to ensure the best outcomes, according to Sally Werner, MSHA, BSN, RN, senior vice president, affiliate relations at Cancer Support Community.

Oncology nurses can make the world of a difference when it comes to patient care, and it is crucial that they work together with other memebers of the treatment team to ensure the best outcomes, according to Sally Werner, MSHA, BSN, RN, senior vice president, affiliate relations at Cancer Support Community.

In this month’s episode of the CURE Talks Cancer Podcast: Nursing Edition, Werner — an oncology nurse by trade – discusses how nurses can be the best advocates for their patients, how to navigate life in the era of “Dr. Google,” and more.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Image of a woman with light brown hair wearing glasses with a blue background
Image of a woman wearing glasses in front of a blue background
Image of a woman with glasses in front of a blue background
Image of a man in a suit smiling in front of an Oncology Nursing News background
Related Content
Photo of the FDA office's sign

Sunvozertinib Granted FDA Accelerated Approval in EGFR Exon 20+ NSCLC

Bridget Hoyt
July 2nd 2025
Article

Sunvozertinib has received accelerated approval for use in advanced or metastatic non–small lung cancer harboring EGFR exon 20 insertion mutations.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

Image of a laptop with the words "FDA Food and Drug Adminstration" visible

Oncology Drugs Approved by the FDA in June

Bridget Hoyt
July 2nd 2025
Article

Oncologic therapies approved in June included indications in genitourinary, lung, and hematologic, and head and neck cancers.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

Graphic of a pair of lungs with tumors

ICI Rechallenge With Anlotinib May Benefit Pretreated ES-SCLC

Roman Fabbricatore
July 1st 2025
Article

Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated with prior immunotherapy.

Photo of a woman with brown hair and bangs, surrounded by a blue border

AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

Michelle Kirschner, RN, MSN, ACNP, APRN-BC
June 30th 2025
Article

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.